<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=780280282443813&amp;ev=PageView&amp;noscript=1">
search

    Cortexyme, Inc.

    verified_userVerify Profile
    Companies » Health Care » Pharmaceuticals & Biotechnology » Pharmaceuticals

    About Cortexyme, Inc.

    Cortexyme is a biopharmaceutical company developing therapeutics based on data supporting a new theory of the cause of Alzheimer's and other degenerative disorders. Cortexyme is targeting a specific pathogen tied to neurodegeneration. The target has been validated in a number of animal models and Cortexyme is enrolling patients in a Phase 2/3 clinical trial of its lead small molecule in mild to moderate Alzheimer's disease. Source

    At A Glance

    • CAPITAL RAISE STATUS
      Not Currently Raising
    • FILING TYPE
      Public
    • PLATFORM TYPE
      NASDAQ
    • RAISED AMOUNT
      $X,XXX,XXX
    • PRE-MONEY EVAULATION
      $442,000,000
    • SIC CODE
      2836
    • NIN CODE
      ####
    • LEADERSHIP
      Casey Lynch
    • FOUNDED
      2012
    • EMPLOYEES
      20
    • SECTOR
      Pharmaceuticals & Biotechnology
    • SUBSECTOR
      Pharmaceuticals

    Company Tags

    No articles found.

    Celcuity Inc.

    Celcuity Inc.

    Celcuity is a cellular analysis company that is discovering new cancer sub-types a...

    Celcuity is a cellular analysis company that is...

    Filing Type:    PU
    Luna Innovations Incorporated

    Luna Innovations Incorporated

    Luna (NASDAQ:LUNA) develops and manufactures new-generation products for the healt...

    Luna (NASDAQ:LUNA) develops and manufactures ne...

    Filing Type:    PU
    Exicure, Inc.

    Exicure, Inc.

    Exicure, Inc. is a clinical stage biotechnology company developing a new class of ...

    Exicure, Inc. is a clinical stage biotechnology...

    Filing Type:    PU
    Antares Pharma, Inc.

    Antares Pharma, Inc.

    Antares Pharma is a specialty pharmaceutical company that combines drug developmen...

    Antares Pharma is a specialty pharmaceutical co...

    Filing Type:    PU
    Aptose Biosciences, Inc.

    Aptose Biosciences, Inc.

    Aptose Biosciences is a clinical-stage biotechnology company developing personaliz...

    Aptose Biosciences is a clinical-stage biotechn...

    Filing Type:    PU
    Avenue Therapeutics, Inc.

    Avenue Therapeutics, Inc.

    Avenue Therapeutics, Inc., a Fortress Biotech (NASDAQ: FBIO) Company, is a special...

    Avenue Therapeutics, Inc., a Fortress Biotech (...

    Filing Type:    PU
    Intra-Cellular Therapies Inc.

    Intra-Cellular Therapies Inc.

    Intra-Cellular Therapies is a biopharmaceutical company developing novel drugs, le...

    Intra-Cellular Therapies is a biopharmaceutical...

    Filing Type:    PU
    WindowMirror Inc

    WindowMirror Inc

    WindowMirror's BUTTERFLY will be a collaborative SaaS (Software as a Service) plat...

    WindowMirror's BUTTERFLY will be a collaborativ...

    Amount Raised:    $14,462.00
    Fundraising Status:    EC
    Filing Type:    CF
    Denali Therapeutics Inc.

    Denali Therapeutics Inc.

    We discover and develop medicines to defeat neurodegeneration. The science is brea...

    We discover and develop medicines to defeat neu...

    Filing Type:    PU
    Karuna Therapeutics, Inc.

    Karuna Therapeutics, Inc.

    We are an innovative clinical-stage biopharmaceutical company primarily focused on...

    We are an innovative clinical-stage biopharmace...

    Filing Type:    PU
    Intra-Cellular Therapies Inc.

    Intra-Cellular Therapies Inc.

    Intra-Cellular Therapies is a biopharmaceutical company developing novel drugs, le...

    Intra-Cellular Therapies is a biopharmaceutical...

    Filing Type:    PU
    Cassava Sciences, Inc.

    Cassava Sciences, Inc.

    The mission of Cassava Sciences is to detect and treat neurodegenerative diseases,...

    The mission of Cassava Sciences is to detect an...

    Filing Type:    PU
    ©2025 National Investor Network. All Rights Reserved.